- 2017
-
Press releases - 14.01.2017
Ebola survivors: life afterwards
In November 2014, Inserm organised medical follow-up of people who survived infection by the Ebola virus. 802 individuals (adults and children) were included in the PostEbogui cohort. Results of follow-up show that on average one year after their initial period in hospital, 3 in 4 survivors still report health problems.
-
Press releases - 10.01.2017
Identification of one of the keys allowing entry of Zika virus into brain cells
L’équipe d’Ali Amara, directeur de recherche Inserm, décrit, dans un article publié dans Cell Reports, les mécanismes permettant au virus Zika d’infecter les cellules du système nerveux.
- 2016
-
Press releases - 21.12.2016
Potential of an immunotherapy demonstrated in the treatment of Alzheimer’s disease
The involvement of the immune system in neurological diseases suggests that immunotherapy, which has shown its effectiveness in the area of cancer and autoimmune diseases, is also of major interest in the treatment of neurodegenerative diseases. The researchers have proven that a molecule called interleukin-2 (IL-2), from the immune system, is able to control inflammation in the brain cells, which is implicated in neurodegenerative diseases such as Alzheimer’s disease, and can restore impaired cognitive functions in the animal model.
-
Press releases - 14.12.2016
Testosterone for nerve fibre repair
To protect against attack, the body uses natural repair processes.
-
Press releases - 14.12.2016
Storage of umbilical cord blood
For the first time in France, a couple has just been given authorisation to entrust a private company with the storage of umbilical cord cells from their unborn child, in view of a potential therapeutic need.
-
What's on? - 14.12.2016
Storage of umbilical cord blood
For the first time in France, a couple has just been given authorisation to entrust a private company with the storage of umbilical cord cells from their unborn child, in view of a potential therapeutic need. In its Order dated 21 November 2016, the Grasse court authorised the couple to “take and store haematopoietic cells […]
-
Press releases - 13.12.2016
Neurons paralyze us during REM sleep
Researchers working in the Centre de Recherche en Neurosciences de Lyon have identified a population of neurons that is responsible for this transient muscle paralysis.
-
News in brief - 05.12.2016
Zika virus infects the human retina
Two Inserm teams involving Unit 1058, “Pathogenesis and Control of Chronic Infections” (Inserm/University of Montpellier/French Blood Transfusion Service) and Unit 1051, “Montpellier Institute of Neurosciences,” have just shown that Zika virus can infect the pigment epithelium of the human retina, and may thus be able to cause retinal damage. This study is published in Journal […]
-
Press releases - 02.12.2016
Minimum effort for maximum effect
Ten days after astronaut Thomas Pesquet take-off into space on the Proxima mission, many questions remain about human adaptation to gravity.
-
Press releases - 01.12.2016
A molecule to regenerate insulin-producing cells in type 1 diabetic patients
Inserm researchers led by Patrick Collombat at Unit 1091,“Institute of Biology Valrose” (Inserm/CNRS/Nice Sophia Antipolis University), show that GABA, a neurotransmitter that is sometimes used as a dietary supplement, can induce the regeneration of insulin-producing cells. This discovery, confirmed in mice and partially validated in humans, gives new hope to patients with type 1 diabetes.
This research is published in the journal Cell.